TriSalus Life Sciences, Inc.

TLSI Nasdaq CIK: 0001826667

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 6272 WEST 91ST AVENUE, WESTMINSTER, CO, 80031
Mailing Address 6272 WEST 91ST AVENUE, WESTMINSTER, CO, 80031
Phone 415 336 8917
Fiscal Year End 1231
EIN 853009869

Financial Overview

FY2025

$69.19M
Total Liabilities
$20.44M
Cash & Equivalents
$-1.31
EPS

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report April 1, 2026 View on SEC
DEF 14A Definitive proxy statement March 31, 2026 View on SEC
4 Insider stock transaction report March 20, 2026 View on SEC
4 Insider stock transaction report March 20, 2026 View on SEC
4 Insider stock transaction report March 20, 2026 View on SEC
4 Insider stock transaction report March 20, 2026 View on SEC
4 Insider stock transaction report March 20, 2026 View on SEC
10-K Annual financial report March 5, 2026 View on SEC
8-K Current report of material events March 5, 2026 View on SEC
424B5 Prospectus supplement February 26, 2026 View on SEC

Annual Reports

10-K March 5, 2026
  • Advancing innovative Pressure-Enabled Drug Delivery™ (PEDD™) platform and therapeutic candidate SD-101 for liver and pancreatic cancers.
  • Achieved significant clinical progress in 2023, including completing Phase 1/2 enrollment and receiving FDA Orphan Drug Designation for SD-101.
View Analysis

Insider Trading

STRONG BUY 9 insiders 20 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.